IL6 is a well know biomarker in diseases of the central nervous system (CNS), such as Alzheimer’s Disease (AD), Parkinson’s Disease (PD) or Huntington’s disease (HD), due to its consistent upregulation whenever neuroinflammation is expected (37). This evidence concerns the gene IL6 and juvenile Huntington disease.